Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $10.0200 (-3.09%) ($10.0200 - $10.0200) on Fri. Mar. 25, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.43% (three month average) | RSI | 62 | Latest Price | $10.0200(-3.09%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | TGTX advances 7.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(76%) ARKG(72%) IBB(69%) ARKK(66%) IBUY(61%) | Factors Impacting TGTX price | TGTX will decline at least -3.715% in a week (0% probabilities). VIXM(-49%) VXX(-42%) UUP(-24%) TBT(-13%) UNG(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.715% (StdDev 7.43%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $10.07(-0.5%) | 10 Day Moving Average | $9.5(5.47%) | 20 Day Moving Average | $9.37(6.94%) | To recent high | -51% | To recent low | 28.5% | Market Cap | $1.269b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |